Surveillance Strategies in Breast Cancer

Evidence-Based Recommendations

The American Society of Clinical Oncology (ASCO) guidelines list chest X-rays as "NOT RECOMMENDED" for routine breast cancer surveillance in patients with a history of breast cancer 1, 3
Multiple studies have demonstrated no survival benefit from routine chest imaging in asymptomatic patients with a history of breast cancer, according to the American College of Radiology 4, 5
Regular history and physical examinations remain the cornerstone of follow-up care, as recommended by the American Society of Clinical Oncology (ASCO) 1
Annual mammography is the only imaging study recommended for routine surveillance in breast cancer survivors, according to the American Cancer Society 1, 6
Patient education regarding symptoms of recurrence is essential, as recommended by the American Society of Clinical Oncology (ASCO) and the American Cancer Society 3, 6

Chest imaging should be performed only when clinically indicated based on symptoms or physical examination findings, as recommended by the American College of Radiology and the American Cancer Society 1, 6
Symptomatic patients should be evaluated with appropriate imaging as indicated by their specific symptoms, according to the American Thoracic Society 7
Patients who smoke may warrant consideration for chest X-ray, though this should be based on smoking-related risk factors rather than breast cancer history alone, as recommended by the American Cancer Society 7

Ordering routine chest X-rays based on historical practice patterns rather than evidence-based guidelines, as cautioned by the American Society of Clinical Oncology (ASCO) and the American College of Radiology 1, 3
Assuming that more intensive surveillance with imaging studies will lead to better outcomes, as randomized trials have consistently shown no survival benefit, according to the American Cancer Society 6
Failing to educate patients about symptoms that should prompt evaluation, which is more effective than routine imaging, as recommended by the American Cancer Society 6
Ordering advanced imaging (CT, PET) for routine surveillance, which is also not recommended and has even higher false positive rates, as cautioned by the American College of Radiology and the American Society of Clinical Oncology (ASCO) 1, 4